PocketLaw | Illinois Compiled Statutes | Kidney Disease Prevention and

Kidney Disease Prevention and Education Task Force Act.

Checkout our iOS App for a better way to browser and research.

(20 ILCS 5160/Art. 5 heading)

Article 5. Health Care Affordability Act(The Health Care Affordability Act is compiled at 20 ILCS 2230/)

(20 ILCS 5160/Art. 10 heading)

Article 10. Kidney Disease Preventionand Education Task Force Act

(20 ILCS 5160/10-1)

(Section scheduled to be repealed on January 1, 2024)

Sec. 10-1. Short title. This Article may be cited as the Kidney Disease Prevention and Education Task Force Act. References in this Article to "this Act" mean this Article.

(Source: P.A. 101-649, eff. 7-7-20.)

(20 ILCS 5160/10-5)

(Section scheduled to be repealed on January 1, 2024)

Sec. 10-5. Findings. The General Assembly finds that:

(1) Chronic kidney disease is the 9th-leading cause of death in the United States. An estimated 31 million people in the United States have chronic kidney disease and over 1.12 million people in the State of Illinois are living with the disease. Early chronic kidney disease has no signs or symptoms and, without early detection, can progress to kidney failure.
(2) If a person has high blood pressure, heart disease, diabetes, or a family history of kidney failure, the risk of kidney disease is greater. In Illinois, 13% of all adults have diabetes, and 32% have high blood pressure. The prevalence of diabetes, heart disease, and hypertension is higher for African Americans, who develop kidney failure at a rate of nearly 4 to 1 compared to Caucasians, while Hispanics develop kidney failure at a rate of 2 to 1. Almost half of the people waiting for a kidney in Illinois identify as African American, but, in 2017, less than 10% of them received a kidney.
(3) Although dialysis is a life-extending treatment, the best and most cost-effective treatment for kidney failure is a kidney transplant. Currently, the wait in Illinois for a deceased donor kidney is 5-7 years, and 13 people die while waiting every day.
(4) If chronic kidney disease is detected early and managed appropriately, the individual can receive treatment sooner to help protect the kidneys, the deterioration in kidney function can be slowed or even stopped, and the risk of associated cardiovascular complications and other complications can be reduced.
(5) In light of the COVID-19 pandemic and the increased risk of infection to patients with preexisting conditions, it is imperative to provide those with kidney disease with support.

(Source: P.A. 101-649, eff. 7-7-20.)

(20 ILCS 5160/10-10)

(Section scheduled to be repealed on June 1, 2024)

Sec. 10-10. Kidney Disease Prevention and Education Task Force.

(a) There is hereby established the Kidney Disease Prevention and Education Task Force to work directly with educational institutions to create health education programs to increase awareness of and to examine chronic kidney disease, transplantations, living and deceased kidney donation, and the existing disparity in the rates of those afflicted between Caucasians and minorities.

(b) The Task Force shall develop a sustainable plan to raise awareness about early detection, promote health equity, and reduce the burden of kidney disease throughout the State, which shall include an ongoing campaign that includes health education workshops and seminars, relevant research, and preventive screenings and that promotes social media campaigns and TV and radio commercials.

(1) one member of the Senate, appointed by the Senate President, who shall serve as Co-Chair;
(2) one member of the House of Representatives, appointed by the Speaker of the House, who shall serve as Co-Chair;
(3) one member of the House of Representatives, appointed by the Minority Leader of the House;
(4) one member of the Senate, appointed by the Senate Minority Leader;
(5) one member representing the Department of Public Health, appointed by the Governor;
(6) one member representing the Department of Healthcare and Family Services, appointed by the Governor;
(7) one member representing a medical center in a county with a population of more 3 million residents, appointed by the Co-Chairs;
(8) one member representing a physician's association in a county with a population of more than 3 million residents, appointed by the Co-Chairs;
(9) one member representing a not-for-profit organ procurement organization, appointed by the Co-Chairs;
(10) one member representing a national nonprofit research kidney organization in the State of Illinois, appointed by the Co-Chairs;
(11) the Secretary of State or his or her designee;
(12) one member who is a dialysis patient, appointed by the Co-Chairs;
(13) one member who is a chronic kidney disease patient, appointed by the Co-Chairs;
(14) one member who is a kidney transplant recipient, appointed by the Co-Chairs;
(15) one member who is a representative of a program working to break down barriers to transplant care in the African American community through access to education, resources, and transplant care, appointed by the Co-Chairs; and
(16) one member who is a representative of a nationwide, non-profit organization with membership for dialysis and pre-dialysis patients and their families, appointed by the Co-Chairs.

(d) Members of the Task Force shall serve without compensation.

(e) The Department of Public Health shall provide administrative support to the Task Force.

(f) The Task Force shall submit its final report to the General Assembly on or before December 31, 2023 and, upon the filing of its final report, is dissolved.

(Source: P.A. 101-649, eff. 7-7-20; 102-671, eff. 11-30-21.)

(20 ILCS 5160/10-15)

(Section scheduled to be repealed on June 1, 2024)

Sec. 10-15. Repeal. This Act is repealed on June 1, 2024.

(Source: P.A. 101-649, eff. 7-7-20; 102-671, eff. 11-30-21.)

(20 ILCS 5160/Art. 90 heading)

Article 90. Amendatory Provisions

(20 ILCS 5160/90-5)

Sec. 90-5. (Amendatory provisions; text omitted).